Thu.Dec 12, 2024

article thumbnail

STAT+: Prices for 5 drugs were hiked without proof of new benefits, costing the U.S. $815M in 2023, report finds

STAT

During 2023, drugmakers substantially raised prices on five widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $815 million last year, according to a new report. The drug for which spending increased the most due to a price increase was Biktarvy, which is prescribed to treat HIV and is a franchise product for Gilead Sciences.

281
281
article thumbnail

Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma

PharmaVoice

100
100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Pharmalittle: We’re reading about unsupported drug price hikes, an annual HIV prevention shot, and more

STAT

Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting across the Pharmalot campus, where the official mascots are snoozing after foraging for their breakfast. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is maple cinnamon French toast.

241
241
article thumbnail

Under-18s puberty blocker ban extended indefinitely following expert advice

The Pharmacist

The UK ban on private prescribing of puberty blockers in under-18s with gender dysphoria has been extended indefinitely, the government has announced. It follows a consultation on the measures and independent advice from the Commission on Human Medicines (CHM) which found an unacceptable safety risk in the continued prescription of puberty blockers to children.

93
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

CDC finds no evidence of bird flu virus in California toddler

STAT

Testing of samples taken from a child in California thought to have contracted H5N1 bird flu after drinking raw milk turned up no evidence of influenza viruses, the Centers for Disease Control and Prevention said Thursday.  A test run on a sample from the child — who went to a Marin County emergency department last week with a fever and vomiting — had been positive there for flu A.

255
255
article thumbnail

Understanding Adrenal Fatigue

Compounding Pharmacy of America

Discover the symptoms, causes, and natural treatments for adrenal fatigue. Learn how tools like the Adrenal Stress Test Kit and targeted supplements can restore balance and energy. The post Understanding Adrenal Fatigue appeared first on Compounding Pharmacy of America.

97

More Trending

article thumbnail

ASBM Responds to PCMA: Put Patients First, Not PBM Profits

Safe Biologics

Press Release ARLINGTON, Va., December 9, 2024 (Newswire.com) – As the Senate moves this week to advance passage of the misleadingly named Biosimilar Red Tape Elimination Act (S. 2035), the Alliance for Safe Biologic Medicines (ASBM) reiterates its opposition to the self-interested efforts of the Pharmaceutical Care Management Association (PCMA), which strongly supports this bill that prioritizes insurance company and pharmacy benefit manager (PBM) profits over patient safety and maintaini

100
100
article thumbnail

STAT+: Arcellx won the battle of BCMA CAR-T therapies

STAT

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up  here  to get it delivered to their inbox. I just returned from San Diego and the annual meeting of the American Society of Hematology, where Arcellx won the battle of BCMA CAR-T therapies against Legend Biotech. Legend has downplayed the significance of the 12-17% rate of delayed neurotoxicity — Parkinsonian symptoms and cranial nerve palsies — report

184
184
article thumbnail

Bayer begins inhibitor study treating advanced KRAS-mutated tumours

Pharma Times

Trial explores potential of therapy in treating multiple cancer types

86
article thumbnail

STAT+: Editas Medicine lays off 65% of staff and shelves lead gene-editing program

STAT

Editas Medicine said Thursday afternoon it will lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell disease and shifts focus.  The cuts come amid a prolonged financial downturn for the gene-editing field, as valuations have plummeted and layoffs have become widespread. Editas already laid off staff as part of a restructuring in 2023.

180
180
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Leriglitazone meets primary endpoint in pivotal cALD trial

Pharma Times

Promising trial results support marketing authorisation application

82
article thumbnail

When AI becomes a tool to fight insurance denials

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday. Companies use AI to fight insurance denials People infrequently challenge health insurance denials even though appeals are often successful.

164
164
article thumbnail

Targeting ovarian cancer with a novel antibody therapeutic

European Pharmaceutical Review

72
article thumbnail

Opinion: In a threat to patient trust, Texas hospitals must ask ‘Are you a U.S. citizen?’

STAT

As a first-generation immigrant, much of my childhood was spent in a state of perpetual uncertainty. My family and I fixated on an ever-refreshing screen, patiently watching our status shift from “H-1B visa” to “green card” holder to “citizen” over 14 long years. Yet amid this endless cycle of anxiety, one place surprisingly gave me solace: the hospital.

143
143
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

UK indefinitely bans puberty blockers for teenagers due to “unacceptable risk”

Pharmaceutical Technology

Puberty blockers for people aged under 18 with gender dysphoria will be indefinitely banned by the UK Government.

66
article thumbnail

STAT+: AI versus AI: The emerging arms race over health insurance denials

STAT

Like many Americans, Holden Karau said she was fed up with health insurance. The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. She said the hassles piled on stress, forced her to pay more out of pocket, and delayed access to care she needed to recover from multiple broken bones.

143
143
article thumbnail

BREAKING: GPhC plans to ‘update’ pharmacy inspections in January

The Pharmacist

The General Pharmaceutical Council (GPhC) has announced plans to update and improve the way it inspects pharmacies. It has outlined a set of proposals to its governing council which include the introduction of shorter, more focused inspections, alongside its full inspections. Under the plans, inspectors will have the option to switch to a full inspection […] The post BREAKING: GPhC plans to update pharmacy inspections in January appeared first on The Pharmacist.

63
article thumbnail

Opinion: What I’ve learned — the hard way — about AI in bio

STAT

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma.  There’s more to life than protein folding.

130
130
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

How to Identify Branded Drugs with a Low Likelihood of Generic Entry as Targets for In-Licensing

Drug Patent Watch

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies. In this comprehensive guide, we’ll explore the intricacies of identifying such drugs and leveraging them for successful in-licensing opportunities.

59
article thumbnail

Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr

Pharmaceutical Technology

In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US publics health in jeopardy.

59
article thumbnail

Addressing Generic Drug Market Challenges: Strategies for Stability and Affordability

Drug Patent Watch

The generic drug market in the United States faces significant challenges, including price volatility, supply chain disruptions, and strategies employed by brand-name manufacturers to delay market entry. These challenges can lead to drug shortages, price spikes, and reduced affordability for patients and payers. To address these issues, several market-based proposals and regulatory reforms have been suggested.

52
article thumbnail

China NMPA approves Santhera’s DMD treatment therapy

Pharmaceutical Technology

Chinas NMPA has granted approval to Santhera Pharmaceuticals AGAMREE, used in treating DMD in individuals aged four years and above.

59
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Pharmacy First antibiotic rates show pharmacists acting responsibly, says CCA

The Pharmacist

New Pharmacy First analysis has suggested pharmacists are treating antimicrobial stewardship with utmost importance and only supplying antibiotics when appropriate. On average, two-thirds (66%) of patients attending pharmacies for earaches, bladder infections, sore throats, sinusitis, infected insect bites or impetigo are provided antibiotics, according to a new report by the Company Chemists Association (CCA).

58
article thumbnail

Meitheal gains US commercial rights for CABP treatment therapy

Pharmaceutical Technology

Meitheal Pharmaceuticals has gained exclusive US commercial rights for XENLETA for treating CABP in the adult population.

59
article thumbnail

Noema Pharma raises $147 million to develop drugs for neurological conditions

Outsourcing Pharma

Noema Pharma extends its series B funding to $147M, advancing phase 2 trials for CNS disorders like Tourette syndrome, menopause symptoms, and neuropathic pain.

53
article thumbnail

Sanofi’s combo vaccines gain FDA fast track designation

Pharmaceutical Technology

Sanofi has announced that its two combination vaccine candidates have received fast track status from the US FDA.

59
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Keros shares collapse on ‘unanticipated’ setback for lung disease drug

BioPharma Dive

52
article thumbnail

How One Clinical Pharmacist Can Have A Profound Impact On Hospital Readmissions

Proxsys Rx

There are so many reasons Brandi Henneman has had such a positive impact on participation rates for ProxsysRxs Readmission Reduction program at South Carolinas Conway Medical Center. Chief among them, her first-rate professionalism, and her genuinely caring disposition which immediately tells patients she has their best interests at heart. Its a sense of comfort and security that comes from not knowing theyre in the hands of a Clinical Pharmacist whos been known to jump out of perfectly good ai

52
article thumbnail

Bioidentical Hormone Replacement Therapy (BHRT) for Menopause

Compounding Pharmacy of America

Learn how BHRT can naturally relieve menopause symptoms like hot flashes and mood swings. Explore personalized testing and treatments tailored to you. The post Bioidentical Hormone Replacement Therapy (BHRT) for Menopause appeared first on Compounding Pharmacy of America.

52
article thumbnail

Why Healthcare Costs are Surging—And What to Do About it

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

What To Do if Your Prescription Medication is Out of Stock

Compounding Pharmacy of America

Learn how to address medication shortages and backorders with customized solutions. Discover how we help patients access essential medications through compounding services. The post What To Do if Your Prescription Medication is Out of Stock appeared first on Compounding Pharmacy of America.

52